Exhaled nitric oxide levels to guide treatment for children with asthma

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 11, 2016, Pages

  Petsky, Helen L ^a   Kew, Kayleigh M ^b   Chang, Anne B ^a,c  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE;

ASTHMA; CHILD; DISEASE EXACERBATION; DISEASE SEVERITY; EXHALATION; HUMAN; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPIROMETRY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 84998692549     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011439.pub2     Document Type: Review

References (60)

1. de Jongste J, Carraro S, Hop W, the CHARISM Study Group, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. American Journal of Respiratory and Critical Care Medicine 2008;179(2):93-7. [4446814; DOI: 10.1164/rccm.200807-1010OC]
2. Fritsch M, Uxa S, Horak F, Putschoegl B, Dehlink E, Szepfalusi Z, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatric Pulmonology 2006;41(9):855-62. [4446816; DOI: 10.1002/ppul.20455]
3. Peirsman E, Carvelli T, Hage P, Hanssens L, Pattyn L, Raes M, et al. Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial. Pediatric Pulmonology 2014;49(7):624-31. [4446818; DOI:10.1002.ppul.22873]
4. Peirsman, E Response to the Editor: "Fractional exhaled nitric oxide-guided algorithm for children with allergic asthma". Pediatric Pulmonology 2015;50(9):934-5. [4446819; DOI: 10.1002/ppul.23137]
5. Qun Ui, Lee Fractional exhaled nitric oxide-guided algorithm for children with asthma. Pediatric Pulmonology 2015;50(9):932-3. [4446820; DOI: 10.1002/ppul.23115]
6. Petsky H, Li A, Au C, Kynaston J, Turner C, Chang A. Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: a dual centre randomized controlled trial. Pediatric Pulmonology 2015;50(6):535-43. [4446822; DOI: 10.1002/ppul.23064]
7. Pijnenburg M, Bakker E, Hop W, de Jongste J. Titrating steroids on exhaled nitric oxide in children with asthma. American Journal of Respiratory and Critical Care Medicine 2005;172(7):831-6. [4446824; DOI: 10.1164/rccm.200503-4580C]
8. Pike K, Selby A, Price S, Warner J, Connett G, Legg J, et al. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid does in paediatric asthma: a randomised controlled trial. Clinical Respiratory Journal 2013;7(2):204-13. [4446826. DOI: 10.1111/j.1752-699X.2012.00306.x
9. Gruchalla RS, Sampson HA, Matsui E, David G, Gergen PJ, Calatroni A, et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. Journal of Allergy and Clinical Immunology 2009;124(2):213-21. 4446828. DOI: 10.1016/j.jaci2009.05.036.
10. Pedersen S, O'Byrne PM. Exhaled nitric oxide in guideline-based asthma management. Lancet 2008;372(9643):1015-7. [4446829]
11. Szefler S, Mitchell H, Sorkness C, Gergen P, O'Connor G, Morgan W, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008;372(9643):1065-72. [4446830. DOI: 10.1016/S0140-6736(08)61448-8]
12. Taylor DR, Bush A. Clinical use of exhaled nitric oxide measurements. Lancet 2009;373(9661):382. [4446831]
13. Verini M, Consilvio N, Di Pillo S, Cingolani A, Spagnuolo C, Rapino D, et al. FeNO as a marker of airways inflammation: the possible implications in childhood asthma management. Journal of Allergy 2010;2010:pii: 691425. [4446833. DOI: 10.1155/2010/691425]
14. Beerthuizen T, Voorend-van Bergen S, van den Hout W, Vaessen-Verberne A, Brackel H, Landstra A, et al. Cost-effectiveness of FeNO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial. Thorax 2016;71(7):607-13. [4446835; DOI: 10.1136/thoraxjnl-2015-207593]
15. Voorend-van Bergen S, Vaessen-Verberne AA, Brackel HJ, Landstra AM, van den Berg NJ, Hop WC, et al. Monitoring strategies in children with asthma: a randomised controlled trial. Thorax 2015;70(6):543-50. [4446836; DOI: 10.1136/thoraxjnl-2014-206161]
16. Voorend-van Bergen S, Vaessen-Verberne AA, Landstra AM, Brackel HJ, van den Berg NJ, Merkus PJ, et al. Fractional exhaled nitric oxide monitoring does not improve asthma management in children with concordant and discordant asthma phenotypes. American Journal of Respiratory and Critical Care Medicine 2015;192(8):1016-8. [4446837; DOI: 10.1164/rccm.201506-1103LE]
17. Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FeNOtype trial. Chest 2012;142(6):1553-61. [4446839; DOI: 10.1378/ches.12-1310]
18. Calhoun W, Ameredes B, King T, Icitovic N, Bleecker E, Castro M, et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma. JAMA 2012;308(10):987-97. [4446841]
19. Gelb A, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006;129(6):1492-9. [4446843; DOI: 10.1378/chest.129.6.1492]
20. Griese M, Koch M, Latzin P, Beck J. Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. European Journal of Medical Research 2000;5(8):334-40. [4446845; PUBMED: 10958766]
21. Hashimoto S, Ten Brinke A, Roldaan A, van Veen I, Moller G, Sont J, et al. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Thorax 2011;66(6):514-20. [4446847; DOI: 10.1136/thx.2010.153411]
22. Honkoop P, Lijmans R, Termeer E, Snoeck-Stroband J, van den Hout W, Bakker M, et al. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: a cluster-randomized trial in primary care. Journal of Allergy and Clinical Immunology 2015;135(3):682-8. [4446849; DOI: 10.1016/j.jaci.2014.07.016]
23. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999;54(2):108-14. [4446851; DOI: 10.1136/thx.54.2.108]
24. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. American Journal of Respiratory and Critical Care Medicine 2001;164(5):738-43. [4446853; DOI: 10.1164/ ajrccm.164.5.2012125]
25. Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroids: dose-response relationship. European Respiratory Journal 2002;20(3):601-8. [4446855; DOI: 10.1183/09031936.02.00285302]]
26. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide in asthmatic patients. European Respiratory Journal 1996;9(2):196-201. [4446857; PUBMED: 8777950]
27. Kharitonov SA, Konnelly LE, Corradi M, Montuschi P, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002;57(1):889-96. [4446859; DOI: 10.1136/thorax.57.10.889]
28. Lim S, Jatakanon A, Uasuf C, Chung KF, Barnes PJ. Clinical utility of exhaled nitric oxide as a marker of disease activity in asthma. American Journal of Respiratory and Critical Care Medicine 1998;157(3 Suppl):A611. [4446861]
29. Malerba M, Ragnoli B, Radaeli A, Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest 2008;134(4):733-9. [4446863; DOI: 10.1378/chest.08-0763]
30. Burgess L, McCaffery K, Powell H, Murphy VE, Gibson PG, Turner RM. The influence of asthma control on psychosocial outcomes for pregnant women with asthma. Journal of Asthma 2015;52(10):1013-9. [4446865; DOI: 10.3109/02770903.2015.1038833]
31. Powell H, Murphy V, Taylor DR, Hensley M, McCaffery K, Giles W, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011;378(9795):983-90. [4446866; DOI: 10.3109/02770903.2015.1038833]
32. Powell H, Murphy VE, Hensley MJ, Giles W, Clifton VL, Gibson PG. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life. Journal of Asthma 2015;52(10):1023-30. [4446867; DOI: 10.1016/S0140-6736(11)60971-9]]
33. Shaw D, Berry M, Thomas M, Green R, Brightling C, Wardlaw A, et al. The use of exhaled nitric oxide to guide asthma management - a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine 2007;176(3):231-7. [4446869; DOI: 10.1164/rccm.200610-1427OC]
34. Smith AD, Cowan J, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine 2005;352(21):2163-73. [4446871; ISSN00284793]
35. Syk J, Malinovschi, Johansson G, Unden A, Andreasson A, Lekander M, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. Journal of Allergy and Clinical Immunology Practice 2013;1(6):639-48. [4446873; DOI: 10.1016/j.jaip.2013.07.013]
36. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. American Journal of Respiratory and Critical Care Medicine 2005;171(10):1077-82. [4446875; DOI: 10.1164/rccm.200409-1242OC]
37. Duong-Quy S, Hua-Huy T, Doan-Quynh N, Nguyen-Quoc B, Le-Quang K, Tran-Thanh D, et al. A study of exhaled NO (FeNO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country. European Respiratory Journal 2015;46(Suppl 59):PA5013. [4446877]
38. Akinbami LJ, Moorman JE, Garbe PL, Sondik, EJ Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009;123(Suppl 3):S131-45. [DOI: 10.1542/peds.2008-2233C]
39. Anderson HR, Gupta R, Strachan DP, Limb ES. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007;62(1):85-90. [DOI: 10.1136/thx.2006.066407]
40. American Thoracic Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of FeNO. American Journal of Critical Care and Respiratory Medicine 2005;171(8):912-30. [DOI: 10.1164/rccm.200406-710ST]
41. Beerthuizen T, Voorend-van Bergen S, van den Hout W, Vaessen-Verberne A, Brackel H, Landstra A, et al. Cost-effectiveness of FeNO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial. Thorax 2016;71(7):607-13. [DOI: 10.1136/thoraxjnl-2015-207593]
42. British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. www.sign.ac.uk/pdf/SIGN153.pdf (accessed 13 October 2016).
43. Dr Christopher Cates. Visual Rx. Online NNT calculator. http://www.nntonline.net/. Dr Christopher Cates, 2008.
44. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57(7):643-8.
45. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. American Journal of Respiratory and Critical Care Medicine 1998;157(3 (pt 1)):894-8.
46. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. American Journal of Respiratory and Critical Care Medicine 2011;184(5):602-15. [DOI: 10.1164/rccm.9120-11ST]
47. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2016. ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention (accessed 2 August 2016).
48. Gomersal T, Harnan S, Essat M, Tappenden P, Wong R, Lawson R, et al. A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma. Pediatric Pulmonology 2016;51(3):316-28. [DOI: 10.1002/ppul.23371]
49. GRADE Working Group, McMaster University. GRADEpro GDT. GRADE Working Group, McMaster University, 2015.
50. Gupta R, Anderson HR, Strachan DP, Maier W, Watson L. International trends in admissions and drug sales for asthma. International Journal of Tuberculosis and Lung Disease 2006;10(2):138-45.
51. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
52. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils and methacholine responsiveness in patients with mild asthma. Thorax 1998;53(2):91-5.
53. Lu M, Wu B, Che D, Qiao R, Gu H. FeNO and asthma treatment in children. Medicine 2015;94(4):e347. [DOI: 10.1097/MD.0000000000000347]
54. Müller KC, Jorres RA, Magnussen H, Holz O. Comparison of exhaled nitric oxide analysers. Respiratory Medicine 2005;99(5):631-7.
55. National Asthma Council Australia, Melbourne, 2014 Australian asthma handbook, Version 1.0. www.nationalasthma.org.au/handbook (accessed 31 October 2014).
56. National Institute for Health and Care Excellence. Asthma: diagnosing and monitoring of asthma in adults, children and young people. www.nice.org.uk/guidance/indevelopment/gid-cgwave0640/documents (accessed 18 January 2016).
57. Petsky HL, Kew KM, Turner C, Chang AB. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD011440.pub2]
58. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
59. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. British Medical Bulletin 2000;56(4):985-1003.
60. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD006340.pub3]